Nutrition Reviews, 56 (9), 266270
This suggests GLP-1 receptor agonists may improve metabolic health in this high-risk group, who face elevated diabetes and cardiovascular mortality and are often excluded from prior GLP-1 trials
The class III segment dominated the GLP-1 targeted peptide weight loss drugs market in 2024 because individuals with severe obesity have the greatest clinical need and are more likely to be prescribed effective pharmacological treatments
Whitney Evans, director of nutrition and scientific affairs at Danone North America, told Just Food : "This is the first product that Danone North America and Oikos have brought to the yogurt aisle that is specifically created and positioned to support the unique nutrition needs of GLP-1 users and other weight-loss consumers
doi: 10.1056/NEJMoa1612917 23 HondaJ.KimuraT.SakaiS.MaruyamaH.TajiriK.MurakoshiN.et al
There are two flavor profiles available: tropical fruit and sweet and sour, and Hirschlag can confirm theyre equally delicious
